By Your doctor ordered a CRP test. Or maybe it showed up flagged on a routine panel and nobody explained it properly. You’ve looked it up and found either a one-sentence definition or a wall of medical jargon. Neither helps you understand what the number actually means for your health.
Here’s what the CRP test is really measuring, why two different versions of the test exist, what counts as high versus normal, and – most importantly – what to actually do with an elevated result.
What C-Reactive Protein Is
C-reactive protein is a protein produced by the liver. Under normal circumstances, very little of it circulates in your blood. But when your body senses injury, infection, or tissue damage, it triggers an inflammatory response – and one of the things your liver does in response is rapidly ramp up CRP production. Within 6 to 12 hours of an inflammatory trigger, CRP levels can rise dramatically. They also fall quickly once the inflammation resolves.
This makes CRP what’s called an acute-phase reactant – a protein that rises reliably and rapidly during inflammation and falls once the threat passes. It’s been used as a clinical marker since the 1940s, and it remains one of the most commonly ordered inflammatory markers in medicine today.
CRP’s actual biological role is part of the innate immune system. It helps recognize damaged cells and foreign invaders, and it activates the complement system – a set of proteins that work alongside antibodies to clear out pathogens and debris. But for clinical purposes, what matters most is that its blood level reflects the intensity of inflammation happening somewhere in your body.
The key distinction: CRP doesn’t diagnose anything on its own. It tells you that inflammation is present – not what’s causing it, not where it is, and not how serious the underlying problem is. It’s a signal, not a diagnosis.
Two Tests, Two Purposes
This is the part most people find confusing, and it’s often not explained well.
There isn’t just one CRP test – there are two, and they’re used for completely different purposes.
Standard CRP
Standard CRP measures moderate to high levels of inflammation. The test is sensitive enough to detect CRP in the range of roughly 8-1,000 mg/L. It’s used when something acute or overtly inflammatory is suspected – a bacterial infection, a flare of an autoimmune condition, a post-surgical complication, or to track whether treatment for an inflammatory disease is working.
At this scale, normal is generally less than 8-10 mg/L (though lab reference ranges vary). If you have a serious bacterial infection, CRP can shoot up to hundreds of mg/L. If you have active rheumatoid arthritis or inflammatory bowel disease flaring, it can sit chronically elevated in the tens to low hundreds.
High-Sensitivity CRP (hs-CRP)
High-sensitivity CRP uses a more precise assay that can detect very small amounts of CRP – in the range of 0.1 to 10 mg/L. This version is specifically designed to pick up the kind of low-grade, chronic inflammation that doesn’t cause obvious symptoms but quietly contributes to cardiovascular disease over years and decades.
This is a fundamentally different clinical question. You’re not asking “is there active infection or severe inflammation?” You’re asking “is there smoldering background inflammation that raises my heart attack or stroke risk?”
The AHA and CDC jointly issued a statement establishing hs-CRP thresholds for cardiovascular risk assessment, which are now widely used in clinical practice:
| hs-CRP Level | Cardiovascular Risk Category |
|---|---|
| Less than 1.0 mg/L | Low risk |
| 1.0 – 3.0 mg/L | Moderate risk |
| Greater than 3.0 mg/L | High risk |
| Greater than 10 mg/L | Suggests acute inflammation – repeat testing recommended |
When hs-CRP comes back above 10 mg/L, it almost certainly reflects acute illness rather than chronic low-grade inflammation, and most guidelines recommend repeating the test in 2-3 weeks once the acute issue has resolved before drawing any cardiovascular conclusions.
Why CRP Became Part of Heart Disease Risk Assessment
The cardiovascular application of hs-CRP has a specific research history worth understanding, because it explains why your doctor might mention it even when your cholesterol looks fine.
For decades, cardiovascular risk was assessed primarily through cholesterol levels, blood pressure, smoking status, diabetes, and age. These predict risk reasonably well – but not perfectly. A significant portion of heart attacks and strokes occur in people whose traditional risk factors look normal.
Research beginning in the 1990s and accelerating through the 2000s – much of it led by Dr. Paul Ridker at Brigham and Women’s Hospital – showed that inflammation is a fundamental driver of atherosclerosis, not just a consequence of it. Atherosclerosis (the buildup of plaques in artery walls) isn’t just a plumbing problem caused by too much cholesterol. It’s an inflammatory process. Plaques form and rupture partly because of ongoing immune activity in the arterial wall. Elevated hs-CRP reflects this arterial inflammation.
Multiple large prospective studies established that elevated hs-CRP independently predicts future heart attack, stroke, and cardiovascular death – even after adjusting for traditional risk factors. A landmark analysis published in Circulation found that elevated CRP was associated with an approximately 8-fold increase in cardiovascular mortality. A 2025 analysis of nearly 450,000 UK Biobank participants found that individuals with hs-CRP above 3 mg/L had a 34% higher risk of major cardiovascular events and a 61% higher risk of cardiovascular death compared to those with hs-CRP below 1 mg/L.
The JUPITER trial, published in the New England Journal of Medicine in 2008, was a turning point. It demonstrated that people with elevated hs-CRP but relatively normal LDL cholesterol who were treated with rosuvastatin (a statin) had significantly fewer cardiovascular events than those receiving placebo. This established that hs-CRP elevation is not just a risk marker – it identifies a population that may benefit from treatment even when standard lipid numbers don’t clearly indicate risk.
The 2019 ACC/AHA guidelines on primary prevention of cardiovascular disease incorporated hs-CRP as a “risk-enhancing factor” – something to consider when a patient’s 10-year cardiovascular risk falls in an intermediate zone where the decision to start a statin isn’t obvious. An hs-CRP of 2 mg/L or higher in that context can tip the decision toward treatment.
What Raises CRP – and What Causes Chronically Elevated Levels
Because CRP is a nonspecific marker, it can rise for a wide range of reasons. Understanding what drives it helps make sense of an elevated result.
Acute causes – typically produce large rises:
- Bacterial infections (CRP often rises well above 50-100 mg/L in serious bacterial infections; viral infections tend to produce smaller rises)
- Tissue injury – trauma, surgery, burns
- Heart attack – CRP rises sharply after myocardial infarction and can be used to gauge the inflammatory response
- Active flares of autoimmune conditions – rheumatoid arthritis, lupus, inflammatory bowel disease, vasculitis
- Acute pancreatitis
Chronic causes – typically produce low-grade elevation in the hs-CRP range:
- Obesity, particularly visceral (abdominal) fat – adipose tissue produces inflammatory cytokines that chronically stimulate CRP production. This is one of the most common reasons for a mildly elevated hs-CRP in otherwise healthy-appearing Americans.
- Type 2 diabetes and insulin resistance
- Metabolic syndrome
- Smoking – a well-established driver of chronic vascular inflammation
- Hypertension
- Periodontal (gum) disease – chronic oral inflammation significantly raises hs-CRP
- Sedentary lifestyle
- Depression – associated with low-grade inflammatory activation in multiple studies
- Sleep apnea
Things that can temporarily raise CRP and create misleading results:
- Any recent illness, even a mild cold or flu
- Recent vaccination
- Heavy exercise in the past 24-48 hours
- Recent minor injury
- Pregnancy (CRP rises throughout pregnancy)
This is why a single elevated CRP result – particularly a mildly elevated one – needs context. If you had a cold last week or went for a long run the day before your blood draw, the result may not reflect your baseline inflammatory state at all.
What Normal CRP Looks Like – and What “Normal” Really Means
For standard CRP testing: most labs set normal as below 8-10 mg/L, with some using lower cutoffs. A result in this range suggests no significant acute inflammation at the time of testing.
For hs-CRP: the cardiovascular risk thresholds are the most widely referenced benchmarks (below 1 mg/L = low, 1-3 mg/L = moderate, above 3 mg/L = high). The average hs-CRP in middle-aged Americans is approximately 1.5 mg/L, and roughly 25% of the US population has levels above 3 mg/L.
One thing worth knowing: a normal CRP does not rule out significant disease. Some serious conditions produce relatively modest CRP elevation. Some people with established cardiovascular disease have normal hs-CRP. CRP is one piece of a clinical picture, not a final verdict on your health.
What Conditions Are Monitored With CRP
Beyond one-time screening, CRP is used as a monitoring tool in several ongoing conditions:
Rheumatoid arthritis and other inflammatory arthritides: CRP tracks disease activity and helps guide treatment decisions. A falling CRP in response to a new medication is a meaningful signal that the drug is working. A CRP that stays persistently elevated suggests inadequate control.
Inflammatory bowel disease (Crohn’s and ulcerative colitis): CRP correlates reasonably well – though imperfectly – with disease activity. It’s used alongside other markers and clinical symptoms to assess flares and treatment response.
Infection monitoring: In hospitalized patients, tracking serial CRP values over days tells clinicians whether an infection is responding to antibiotics or worsening. CRP typically peaks around 48 hours after the inflammatory trigger and then declines if the cause is being addressed.
Post-surgical monitoring: A CRP that stays elevated or rises beyond the expected post-operative trajectory can signal a surgical complication such as wound infection, anastomotic leak, or deep infection.
Cardiovascular risk reassessment: For patients on statin therapy, hs-CRP is increasingly used to assess whether residual inflammatory risk persists even after LDL is well controlled. Current guidance from the ACC indicates that for patients with persistently elevated hs-CRP despite statin therapy, intensifying lipid-lowering treatment should be considered regardless of LDL level.
How to Lower hs-CRP – What the Evidence Shows
If an elevated hs-CRP is flagged as part of cardiovascular risk assessment, the first line of management is always lifestyle – not medication. The good news is that the things that lower hs-CRP are the same things that lower cardiovascular risk through multiple other pathways.
Diet: The Mediterranean diet consistently lowers hs-CRP in randomized trials. A meta-analysis of Mediterranean diet studies reported a meaningful reduction in hs-CRP. High-fiber diets (both DASH and fiber-supplemented approaches) also reliably reduce CRP, with one trial showing reductions comparable to statin therapy.
Exercise: Regular aerobic exercise reduces chronic low-grade inflammation. Even moderate-intensity exercise – the 150 minutes per week recommended by the CDC and AHA – is associated with lower hs-CRP over time.
Weight loss: Because visceral fat is a major driver of inflammatory cytokine production, losing body weight – particularly abdominal fat – substantially lowers hs-CRP. Even 5-10% weight loss produces measurable reductions.
Smoking cessation: Smoking drives vascular inflammation. CRP falls after quitting.
Treating underlying conditions: If elevated CRP is driven by poorly controlled diabetes, sleep apnea, gum disease, or another identifiable condition, addressing the underlying driver is more important than any specific anti-inflammatory intervention.
Statins: Beyond their cholesterol-lowering effects, statins have anti-inflammatory properties and lower hs-CRP independently. This is part of the mechanism behind the JUPITER trial findings. The ACC now recommends considering statin initiation or intensification in patients with persistently elevated hs-CRP (2 mg/L or higher), irrespective of LDL levels.
Frequently Asked Questions
If my hs-CRP is elevated but my cholesterol is normal, should I be worried? An elevated hs-CRP with normal cholesterol is exactly the scenario the test was designed to identify. Inflammation and cholesterol are independent drivers of cardiovascular risk – you can have one without the other, and having both compounds the risk significantly. If your hs-CRP is persistently above 2-3 mg/L, that’s worth discussing with your doctor, particularly if you have other risk factors like a family history of early heart disease, hypertension, or diabetes.
Can a one-time CRP result be used to assess long-term risk? Research shows that hs-CRP levels are relatively stable over time in individuals without acute illness, which is why a single measurement has meaningful predictive value. That said, if the result seems inconsistent with your overall health picture, or if you were recently ill, a repeat test after a few weeks gives a more reliable reading of your baseline.
Does a high CRP mean I have cancer or a serious illness? Not necessarily. Very high CRP (above 100 mg/L) does warrant investigation for serious infection, significant inflammatory disease, or in some cases malignancy. But mildly or moderately elevated hs-CRP is far more commonly explained by lifestyle factors – obesity, sedentary habits, smoking, poor diet – than by serious underlying disease. Context and clinical judgment matter enormously here.
Is there a difference between ESR and CRP? My doctor ordered both. Both ESR (erythrocyte sedimentation rate) and CRP are inflammatory markers, but they behave differently. CRP rises and falls quickly – within hours to days – and is more responsive to acute changes. ESR is slower, rising over days and persisting for weeks. ESR is also less specific and affected by more variables including age, sex, and anemia. Together they provide complementary information – particularly useful in monitoring chronic autoimmune conditions like polymyalgia rheumatica, where ESR is still the primary marker used.
Do I need to fast before a CRP test? No. Unlike cholesterol testing or blood glucose, CRP is not meaningfully affected by recent food intake. You don’t need to fast. However, avoid testing during or immediately after an acute illness, recent surgery, or significant physical exertion, as these can temporarily inflate the result.
Disclaimer
This article is for educational purposes only and does not constitute medical advice. CRP and hs-CRP results must be interpreted by a qualified healthcare provider in the full context of your medical history, symptoms, and other test findings. Do not use this article to self-diagnose or make decisions about medications or treatment.
References
- Ridker PM. C-reactive protein and cardiovascular disease. Circulation. 2003;108(12):e81-e85. https://www.ahajournals.org/doi/10.1161/01.cir.0000093381.57779.67
- Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107(3):499-511. https://doi.org/10.1161/01.CIR.0000052939.59093.45
- Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein (JUPITER trial). New England Journal of Medicine. 2008;359(21):2195-2207. https://doi.org/10.1056/NEJMoa0807646
- Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. Journal of the American College of Cardiology. 2019;74(10):e177-e232. https://doi.org/10.1016/j.jacc.2019.03.010
- American College of Cardiology. hsCRP: A Promising Risk Assessment Tool. ACC.org. 2025. https://www.acc.org/latest-in-cardiology/articles/2025/12/01/01/prioritizing-health-hscrp
- Poller WC, et al. C-reactive protein and cardiovascular risk in the general population. European Heart Journal. 2025. https://doi.org/10.1093/eurheartj/ehaf937
- Medscape. High-Sensitivity C-Reactive Protein (hs-CRP) – Reference Range, Interpretation, Collection and Panels. https://emedicine.medscape.com/article/2094831-overview
- Ballantyne CM, et al. The use of high-sensitivity C-reactive protein in clinical practice. PMC. 2009. https://pmc.ncbi.nlm.nih.gov/articles/PMC2639398/
- National Institutes of Health – MedlinePlus. C-Reactive Protein (CRP) Test. https://medlineplus.gov/lab-tests/c-reactive-protein-crp-test/
- American Heart Association. hsCRP Insights for Healthcare Professionals. https://professional.heart.org/en/education/hscrp-insights-for-healthcare-professionals
